» Articles » PMID: 33704461

Fate or Coincidence: Do COPD and Major Depression Share Genetic Risk Factors?

Overview
Journal Hum Mol Genet
Date 2021 Mar 11
PMID 33704461
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Major depressive disorder (MDD) is a common comorbidity in chronic obstructive pulmonary disease (COPD), affecting up to 57% of patients with COPD. Although the comorbidity of COPD and MDD is well established, the causal relationship between these two diseases is unclear. A large-scale electronic health record clinical biobank and genome-wide association study summary statistics for MDD and lung function traits were used to investigate potential shared underlying genetic susceptibility between COPD and MDD. Linkage disequilibrium score regression was used to estimate genetic correlation between phenotypes. Polygenic risk scores (PRS) for MDD and lung function traits were developed and used to perform a phenome-wide association study (PheWAS). Multi-trait-based conditional and joint analysis identified single-nucleotide polymorphisms (SNPs) influencing both lung function and MDD. We found genetic correlations between MDD and all lung function traits were small and not statistically significant. A PRS-MDD was significantly associated with an increased risk of COPD in a PheWAS [odds ratio (OR) = 1.12, 95% confidence interval (CI): 1.09-1.16] when adjusting for age, sex and genetic ancestry, but this relationship became attenuated when controlling for smoking history (OR = 1.08, 95% CI: 1.04-1.13). No significant associations were found between the lung function PRS and MDD. Multi-trait-based conditional and joint analysis identified three SNPs that may contribute to both traits, two of which were previously associated with mood disorders and COPD. Our findings suggest that the observed relationship between COPD and MDD may not be driven by a strong shared genetic architecture.

Citing Articles

Associations of Depressive and Anxiety Disorders with Pulmonary Disorders in the Community: The PneumoLaus and PsyCoLaus Studies.

Touilloux B, Casutt A, Strippoli M, Lenoir A, Janett S, Vollenweider P Respiration. 2024; 103(8):503-512.

PMID: 38417406 PMC: 11309049. DOI: 10.1159/000537918.


Unraveling the causality between chronic obstructive pulmonary disease and its common comorbidities using bidirectional Mendelian randomization.

Wang Z, Sun Y Eur J Med Res. 2024; 29(1):143.

PMID: 38403592 PMC: 10895842. DOI: 10.1186/s40001-024-01686-x.


Relationship between serum Th1/Th2 imbalance and depression in elderly patients with COPD and its clinical implications.

Zhang T, Wang G, Li Q, Yan P, Sun J, Jin Y Technol Health Care. 2023; 31(6):2047-2058.

PMID: 37694327 PMC: 10741335. DOI: 10.3233/THC-230665.


The Impact of Anxiety and Depression in Chronic Obstructive Pulmonary Disease.

Rahi M, Thilagar B, Balaji S, Prabhakaran S, Mudgal M, Rajoo S Adv Respir Med. 2023; 91(2):123-134.

PMID: 36960961 PMC: 10037643. DOI: 10.3390/arm91020011.


De novo discovery of traits co-occurring with chronic obstructive pulmonary disease.

Golovina E, Fadason T, Jaros R, Kumar H, John J, Burrowes K Life Sci Alliance. 2022; 6(3).

PMID: 36574990 PMC: 9795035. DOI: 10.26508/lsa.202201609.

References
1.
Baselmans B, Yengo L, van Rheenen W, Wray N . Risk in Relatives, Heritability, SNP-Based Heritability, and Genetic Correlations in Psychiatric Disorders: A Review. Biol Psychiatry. 2020; 89(1):11-19. DOI: 10.1016/j.biopsych.2020.05.034. View

2.
Wootton R, Richmond R, Stuijfzand B, Lawn R, Sallis H, Taylor G . Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study. Psychol Med. 2019; 50(14):2435-2443. PMC: 7610182. DOI: 10.1017/S0033291719002678. View

3.
Robinson J, Wei W, Roden D, Denny J . Defining Phenotypes from Clinical Data to Drive Genomic Research. Annu Rev Biomed Data Sci. 2021; 1:69-92. PMC: 8186527. DOI: 10.1146/annurev-biodatasci-080917-013335. View

4.
Yohannes A, Alexopoulos G . Depression and anxiety in patients with COPD. Eur Respir Rev. 2014; 23(133):345-9. PMC: 4523084. DOI: 10.1183/09059180.00007813. View

5.
Busch R, Cho M, Silverman E . Progress in disease progression genetics: dissecting the genetic origins of lung function decline in COPD. Thorax. 2017; 72(5):389-390. DOI: 10.1136/thoraxjnl-2016-209666. View